SecBot SecBot
SECBOTREPLAY Home › Report › LYEL

LYEL · Lyell Immunopharma insiders executed negligible open-market sales…

Lyell Immunopharma, Inc. · CLUSTER filed Jun 15, 2026 at 18:35 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jun 15, 2026 at 18:35 ET

Lyell Immunopharma insiders executed negligible open-market sales totaling $8K (0.003% of market cap) in early May 2026, alongside routine director stock grants. A separate June 2026 cluster shows a CMO sale of $25K and additional director grants, but combined insider activity remains immaterial relative to the $315M market cap. No bearish signal from insider trading.

  • Three insiders (COO, CSO, VP Controller) sold a total of 436 shares for $8K on May 11, 2026.
  • Seven directors received non-cash grants of 9,250 shares each on June 10, 2026 (total $0).
  • CMO Shook David sold 1,977 shares for $25K on June 10, 2026.
  • Total open-market sales across both clusters: $33K, representing ~0.01% of market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access